Jazz Pharmaceuticals
JAZZ
JAZZ
485 hedge funds and large institutions have $8.81B invested in Jazz Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 73 funds opening new positions, 182 increasing their positions, 138 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
3.62% less ownership
Funds ownership: 92.78% → 89.16% (-3.6%)
11% less funds holding in top 10
Funds holding in top 10: 9 → 8 (-1)
51% less call options, than puts
Call options by funds: $28.3M | Put options by funds: $58.4M
Holders
485
Holding in Top 10
8
Calls
$28.3M
Puts
$58.4M
Top Buyers
| 1 | +$100M | |
| 2 | +$65.2M | |
| 3 | +$53.8M | |
| 4 |
LSV Asset Management
Chicago,
Illinois
|
+$47M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
+$37.8M |
Top Sellers
| 1 | -$220M | |
| 2 | -$105M | |
| 3 | -$105M | |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$76.2M |
| 5 |
SC
Samlyn Capital
New York
|
-$67.1M |